Skip to main content
Top
Published in:

Open Access 01-12-2017 | Research

Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson’s disease

Authors: Xin-Ling Su, Xiao-Guang Luo, Hong Lv, Jun Wang, Yan Ren, Zhi-Yi He

Published in: Translational Neurodegeneration | Issue 1/2017

Login to get access

Abstract

Background

Subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment for Parkinson’s disease (PD), the predictive effect of levodopa responsiveness on surgical outcomes was confirmed by some studies, however there were different conclusions about that through long- and short-term follow-ups. We aimed to investigate the factors which influence the predictive value of levodopa responsiveness, and discover more predictive factors of surgical outcomes.

Methods

Twenty-three PD patients underwent bilateral STN-DBS and completed our follow-up. Clinical evaluations were performed 1 week before and 3 months after surgery.

Results

STN-DBS significantly improved motor function of PD patients after 3 months; preoperative levodopa responsiveness and disease subtype predicted the effect of DBS on motor function; gender, disease duration and duration of motor fluctuations modified the predictive effect of levodopa responsiveness on motor improvement; the duration of motor fluctuations and severity of preoperative motor symptoms modified the predictive effect of disease subtype on motor improvement.

Conclusions

The intensity of levodopa responsiveness served as a predictor of motor improvement more accurately in female patients, patients with shorter disease duration or shorter motor fluctuations; PD patients with dominant axial symptoms benefit less from STN-DBS compared to those with limb-predominant symptoms, especially in their later disease stage.
Literature
1.
2.
go back to reference Tao Y, Liang G. Effect of subthalamic nuclei electrical stimulation in the treatment of Parkinson's disease. Cell Biochem Biophys. 2015;71(1):113–7.CrossRefPubMed Tao Y, Liang G. Effect of subthalamic nuclei electrical stimulation in the treatment of Parkinson's disease. Cell Biochem Biophys. 2015;71(1):113–7.CrossRefPubMed
3.
go back to reference Chiou SM, Lin YC, Huang HM. One-year outcome of bilateral Subthalamic stimulation in Parkinson disease: an eastern experience. World Neurosurg. 2015;84(5):1294–8.CrossRefPubMed Chiou SM, Lin YC, Huang HM. One-year outcome of bilateral Subthalamic stimulation in Parkinson disease: an eastern experience. World Neurosurg. 2015;84(5):1294–8.CrossRefPubMed
4.
go back to reference Kim HY, Chang WS, Kang DW, Sohn YH, Lee MS, Chang JW. Factors related to outcomes of subthalamic deep brain stimulation in Parkinson's disease. J Korean Neurosurg Soc. 2013;54(2):118–24.CrossRefPubMedPubMedCentral Kim HY, Chang WS, Kang DW, Sohn YH, Lee MS, Chang JW. Factors related to outcomes of subthalamic deep brain stimulation in Parkinson's disease. J Korean Neurosurg Soc. 2013;54(2):118–24.CrossRefPubMedPubMedCentral
5.
go back to reference Tir M, Devos D, Blond S, Touzet G, Reyns N, Duhamel A, Cottencin O, Dujardin K, Cassim F, Destée A, Defebvre L, Krystkowiak P. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. Neurosurgery. 2007;61(2):297–304.CrossRefPubMed Tir M, Devos D, Blond S, Touzet G, Reyns N, Duhamel A, Cottencin O, Dujardin K, Cassim F, Destée A, Defebvre L, Krystkowiak P. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. Neurosurgery. 2007;61(2):297–304.CrossRefPubMed
6.
go back to reference Li J, Zhang Y, Li Y. Long-term follow-up of bilateral subthalamic nucleus stimulation in Chinese Parkinson's disease patients. Br J Neurosurg. 2015;29(3):329–33.CrossRefPubMed Li J, Zhang Y, Li Y. Long-term follow-up of bilateral subthalamic nucleus stimulation in Chinese Parkinson's disease patients. Br J Neurosurg. 2015;29(3):329–33.CrossRefPubMed
7.
go back to reference Jiang LL, Liu JL, Fu XL, Xian WB, Gu J, Liu YM, Ye J, Chen J, Qian H, Xu SH, et al. Long-term efficacy of Subthalamic nucleus deep brain stimulation in Parkinson's disease: a 5-year follow-up study in China. Chin Med J. 2015;128(18):2433–8.CrossRefPubMedPubMedCentral Jiang LL, Liu JL, Fu XL, Xian WB, Gu J, Liu YM, Ye J, Chen J, Qian H, Xu SH, et al. Long-term efficacy of Subthalamic nucleus deep brain stimulation in Parkinson's disease: a 5-year follow-up study in China. Chin Med J. 2015;128(18):2433–8.CrossRefPubMedPubMedCentral
8.
go back to reference Charles PD, Blercom NV, Krack P, Lee SL, Xie J, Besson G, Benabid A-L, Pollak P. Predictors of effective bilateral subthalamic nucleusstimulation for PD. Neurology. 2002;59:932–4.CrossRefPubMed Charles PD, Blercom NV, Krack P, Lee SL, Xie J, Besson G, Benabid A-L, Pollak P. Predictors of effective bilateral subthalamic nucleusstimulation for PD. Neurology. 2002;59:932–4.CrossRefPubMed
9.
go back to reference Tsai ST, Lin SH, Chou YC, Pan YH, Hung HY, Li CW, Lin SZ, Chen SY. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects. Stereotact Funct Neurosurg. 2009;87(4):241–8.CrossRefPubMed Tsai ST, Lin SH, Chou YC, Pan YH, Hung HY, Li CW, Lin SZ, Chen SY. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects. Stereotact Funct Neurosurg. 2009;87(4):241–8.CrossRefPubMed
10.
go back to reference Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, Horak FB, Okun MS, Foote KD, Krack P, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011;68(2):165.CrossRefPubMed Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, Horak FB, Okun MS, Foote KD, Krack P, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011;68(2):165.CrossRefPubMed
11.
go back to reference Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the Subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 1998;339:1105–11.CrossRefPubMed Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the Subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 1998;339:1105–11.CrossRefPubMed
12.
go back to reference Hughes AJDS, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–4.CrossRefPubMedPubMedCentral Hughes AJDS, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–4.CrossRefPubMedPubMedCentral
13.
go back to reference Volkmann J, Moro E, Pahwa R. Basic algorithms for the programming of deep brain stimulation in Parkinson's disease. Mov Disord. 2006;21(Suppl 14):S284–9.CrossRefPubMed Volkmann J, Moro E, Pahwa R. Basic algorithms for the programming of deep brain stimulation in Parkinson's disease. Mov Disord. 2006;21(Suppl 14):S284–9.CrossRefPubMed
14.
go back to reference Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992;7(1):2–13.CrossRefPubMed Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992;7(1):2–13.CrossRefPubMed
15.
go back to reference Albanese A, Bonuccelli U, Brefel C, Chaudhuri KR, FRCP CC, Eichhorn T, Melamed E, Pollak P, Laar TV, Zappia M. Consensus statement on the role of acute dopaminergicchallenge in Parkinson s disease. Mov Disord. 2001;16:197–201.CrossRefPubMed Albanese A, Bonuccelli U, Brefel C, Chaudhuri KR, FRCP CC, Eichhorn T, Melamed E, Pollak P, Laar TV, Zappia M. Consensus statement on the role of acute dopaminergicchallenge in Parkinson s disease. Mov Disord. 2001;16:197–201.CrossRefPubMed
16.
go back to reference Merola A, Romagnolo A, Bernardini A, Rizzi L, Artusi CA, Lanotte M, Rizzone MG, Zibetti M, Lopiano L. Earlier versus later subthalamic deep brain stimulation in Parkinson's disease. Parkinsonism Relat Disord. 2015;21(8):972–5.CrossRefPubMed Merola A, Romagnolo A, Bernardini A, Rizzi L, Artusi CA, Lanotte M, Rizzone MG, Zibetti M, Lopiano L. Earlier versus later subthalamic deep brain stimulation in Parkinson's disease. Parkinsonism Relat Disord. 2015;21(8):972–5.CrossRefPubMed
17.
go back to reference Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010;25(15):2649–53.CrossRefPubMed Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010;25(15):2649–53.CrossRefPubMed
18.
go back to reference Jankovic J, McDermott M, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, Stern M, et al. Variable expression of Parkinson s disease: a base-line analysis of the DATATOP cohort. Neurology. 1990;40(10):1529–34.CrossRefPubMed Jankovic J, McDermott M, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, Stern M, et al. Variable expression of Parkinson s disease: a base-line analysis of the DATATOP cohort. Neurology. 1990;40(10):1529–34.CrossRefPubMed
19.
go back to reference Maetzler W, Liepelt I, Berg D. Progression of Parkinson's disease in the clinical phase potential markers. Lancet Neurol. 2009;8:1158–71.CrossRefPubMed Maetzler W, Liepelt I, Berg D. Progression of Parkinson's disease in the clinical phase potential markers. Lancet Neurol. 2009;8:1158–71.CrossRefPubMed
20.
go back to reference Mestre TA, Espay AJ, Marras C, Eckman MH, Pollak P, Lang AE. Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better. Mov Disord. 2014;29(14):1751–6.CrossRefPubMed Mestre TA, Espay AJ, Marras C, Eckman MH, Pollak P, Lang AE. Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better. Mov Disord. 2014;29(14):1751–6.CrossRefPubMed
21.
go back to reference Deuschl G, Schupbach M, Knudsen K, Pinsker MO, Cornu P, Rau J, Agid Y, Schade-Brittinger C. Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord. 2013;19(1):56–61.CrossRefPubMed Deuschl G, Schupbach M, Knudsen K, Pinsker MO, Cornu P, Rau J, Agid Y, Schade-Brittinger C. Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord. 2013;19(1):56–61.CrossRefPubMed
22.
go back to reference Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21(Suppl 14):S290–304.CrossRefPubMed Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21(Suppl 14):S290–304.CrossRefPubMed
23.
go back to reference Leranth CRR, Elsworth JD, Naftolin F, Horvath TL, Redmond DE Jr. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci. 2000;20:8604–9.PubMed Leranth CRR, Elsworth JD, Naftolin F, Horvath TL, Redmond DE Jr. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci. 2000;20:8604–9.PubMed
25.
go back to reference Gillies GE, Murray HE, Dexter D, McArthur S. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease. Pharmacol Biochem Behav. 2004;78(3):513–22.CrossRefPubMed Gillies GE, Murray HE, Dexter D, McArthur S. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease. Pharmacol Biochem Behav. 2004;78(3):513–22.CrossRefPubMed
26.
go back to reference Yadav R, Shukla G, Goyal V, Singh S, Behari M. A case control study of women with Parkinson's disease and their fertility characteristics. J Neurol Sci. 2012;319(1–2):135–8.CrossRefPubMed Yadav R, Shukla G, Goyal V, Singh S, Behari M. A case control study of women with Parkinson's disease and their fertility characteristics. J Neurol Sci. 2012;319(1–2):135–8.CrossRefPubMed
27.
go back to reference Gerlach M, Riederer P. Animal models of Parkinson’s disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm. 2006;103:987–1041.CrossRef Gerlach M, Riederer P. Animal models of Parkinson’s disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm. 2006;103:987–1041.CrossRef
28.
go back to reference Dluzen DE, McDermott JL, Liu B. Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. J Neurochem. 1996;66:658–66.CrossRefPubMed Dluzen DE, McDermott JL, Liu B. Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. J Neurochem. 1996;66:658–66.CrossRefPubMed
29.
go back to reference Bejjani BP, Gervais D, Arnulf I, Papadopoulos S, Demeret S, Bonnet AM, Cornu P, Damier P, Agid Y. Axial parkinsonian symptoms can be improved:the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2000;68:595–600.CrossRefPubMedPubMedCentral Bejjani BP, Gervais D, Arnulf I, Papadopoulos S, Demeret S, Bonnet AM, Cornu P, Damier P, Agid Y. Axial parkinsonian symptoms can be improved:the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2000;68:595–600.CrossRefPubMedPubMedCentral
30.
go back to reference Devos D, Defebvre L, Bordet R. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease. Fundam Clin Pharmacol. 2010;24(4):407–21.CrossRefPubMed Devos D, Defebvre L, Bordet R. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease. Fundam Clin Pharmacol. 2010;24(4):407–21.CrossRefPubMed
31.
go back to reference Fasano A, Aquino CC, Krauss JK, Honey CR, Bloem BR. Axial disability and deep brain stimulation in patients with Parkinson disease. Nat Rev Neurol. 2015;11(2):98–110.CrossRefPubMed Fasano A, Aquino CC, Krauss JK, Honey CR, Bloem BR. Axial disability and deep brain stimulation in patients with Parkinson disease. Nat Rev Neurol. 2015;11(2):98–110.CrossRefPubMed
32.
go back to reference Coelho M, Ferreira JJ. Late-stage Parkinson disease. Nat Rev Neurol. 2012;8(8):435–42.PubMed Coelho M, Ferreira JJ. Late-stage Parkinson disease. Nat Rev Neurol. 2012;8(8):435–42.PubMed
Metadata
Title
Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson’s disease
Authors
Xin-Ling Su
Xiao-Guang Luo
Hong Lv
Jun Wang
Yan Ren
Zhi-Yi He
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Translational Neurodegeneration / Issue 1/2017
Electronic ISSN: 2047-9158
DOI
https://doi.org/10.1186/s40035-017-0084-6